Slate, Redx to reach NASDAQ via reverse mergers: Deals Report

Reverse mergers remain in fashion as a way for private biotechs to reach NASDAQ, as a steady stream of available shell companies have continued to enter deals with ambitious venture-backed start-ups.

In many cases, syndicates have provided nine-digit sums in concurrent placements to support the combined companies, effectively allowing the formerly private entity to achieve a listing and raise cash without a traditional IPO...